Research Article| Volume 98, ISSUE 4, SUPPLEMENT 1, 74S-78S, April 24, 1995

Anxiety and persistence of Lyme disease

  • Author Footnotes
    1 From the Division of Rheumatology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey.
    Leonard H. Sigal
    Requests for reprints should be addressed to Leonard M. Sigal, M.D., 1 Robert Wood Johnson Place MEB 484, New Brunswick, New Jersey 08903-0019.
    1 From the Division of Rheumatology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey.
    New Brunswick, New Jersey
    Search for articles by this author
  • Author Footnotes
    1 From the Division of Rheumatology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey.
      This paper is only available as a PDF. To read, Please Download here.
      Lyme disease has become a major concern in endemic areas, in large measure because of fears that it does not respond to current antibiotic regimens. This anxiety has led to the use of untested drugs and longer courses of therapy than have been demonstrated to be necessary, with attendant increase in cost and toxicity. Concern about the lack of response to such therapy has convinced many patients that they have a permanent disease, with profound effects on their lives and those of their families. A better understanding of the natural history of Lyme disease and of possible causes for persisting symptoms other than active infection is needed to optimize management of such patients. Most symptoms persisting after adequate therapy can be explained by a small number of pathogenic mechanisms, only one of which is ongoing infection. Individualization of care and prudent analysis are crucial if overdiagnosis and overtreatment of Lyme disease are to be avoided.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Sigal LH
        Experience with the first one hundred patients referred to a Lyme disease referral center.
        Am J Med. 1990; 88: 577-581
        • Hsu V
        • Patella SJ
        • Sigal LH
        “Chronic Lyme disease” as the incorrect diagnosis in patients with fibromyalgia.
        Arthritis Rheum. 1993; 36: 1493-1500
        • Sigal LH
        • Patella SJ
        Lyme arthritis as the incorrect diagnosis in pediatric and adolescent fibromyalgia.
        Pediatrics. 1992; 90: 523-528
        • Dinerman H
        • Steere AC
        Fibromyalgia following Lyme disease: association with neurologic involvement and lack of response to antibiotic therapy.
        Arthritis Rheum. 1990; 33: S136
        • Steere AC
        • Taylor E
        • McHugh GL
        • Logigian EL
        The overdiagnosis of Lyme disease.
        JAMA. 1993; 269: 1812-1816
        • Sigal LH
        Current drug therapy recommendations for the treatment of Lyme disease.
        Drugs. 1992; 43: 683-699
        • Rahn DW
        • Malawista SE
        Lyme disease: recommendations for diagnosis and treatment.
        Ann Intern Med. 1991; 114: 472-481
        • Preac-Mursic V
        • Weber K
        • Pfister HW
        • et al.
        Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis.
        Infection. 1989; 17: 355-359
        • Montgomery RR
        • Nathanson MH
        • Malawista SE
        The fate of Borrelia burgdorferi, the agent for Lyme disease, in mouse macrophages.
        J Immunol. 1993; 150: 909-915
        • Genese C
        • Finelli L
        • Parkin W
        • Spitalny KC
        • Centers for Disease Control
        Ceftri-axone-associated biliary complications of treatment of suspected disseminated Lyme disease—New Jersey 1990–1992.
        MMWR. 1993; 42: 39-42
        • Garcia-Monco JC
        • Viller BF
        • Alen JC
        • Benach JL
        Borrelia burgdorferi in the central nervous system: experimental and clinical evidence for early invasion.
        J Infect Dis. 1990; 161: 1187-1193
        • Luft BJ
        • Steinman CR
        • Neimark HC
        • et al.
        Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection.
        JAMA. 1992; 267: 1364-1367
        • Sigal LH
        Immunopathogenic mechanisms in Lyme borreliosis.
        Clin Dermatol. 1993; 11: 415-422
        • Szczepanski A
        • Benach JL
        Lyme borreliosis: host response to Borrelia burgdorferi.
        Microbiol Rev. 1991; 55: 21-34
        • Sigal LH
        Persisting complaints of Lyme disease: a conceptual review.
        Am J Med. 1994; 96: 365-374
        • Sigal LH
        Editorial: The role of the Borrelia burgdorferi polymerase chain reaction assay in the diagnosis of Lyme disease.
        Ann Intern Med. 1994; 120: 520-521
        • Finkel MJ
        • Halperin JJ
        Nervous system Lyme borreliosis—revisited.
        Arch Neurol. 1992; 49: 102-107
        • Halperin JJ
        • Heyes MP
        Neuroactive kynurenines in Lyme borreliosis.
        Neurology. 1992; 42: 43-50
        • Steere AC
        Lyme disease.
        N Engl J Med. 1989; 321: 586-596
        • Sigal LH
        Academy of Medicine of New Jersey Lyme Disease Task Force.
        in: Lyme Disease in New Jersey: A Practical Guide for New Jersey Clinicians. The Academy of Medicine of New Jersey, Lawrenceville, NJ1993
        • Golightly MG
        Lyme borreliosis: clinical laboratory considerations.
        in: Presented at the Sixth International Conference on Lyme Borreliosis, Bologna, ItalyJune 1994
        • Lightfoot Jr, RW
        • Luft BJ
        • Rahn DW
        • et al.
        Treatment of “possible Lyme disease”. A practical policy position of the American College of Rheumatology and the Infectious Disease Society of America based on cost-benefit analysis.
        Ann Intern Med. 1993; 119: 503-509